Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular surface and pharmacokinetics].

C Creuzot-Garcher1

  • 1Service d'Ophtalmologie, CHU, Dijon, France.

Journal Francais D'Ophtalmologie
|May 9, 2007
PubMed
Summary
This summary is machine-generated.

This survey reviews pharmacokinetic and microbiology principles for the ocular surface, a delicate interface between the body and the external environment. Understanding these rules is crucial for maintaining ocular surface health and managing infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mirvetuximab soravtansine-associated microcystic keratopathy].

Journal francais d'ophtalmologie·2026
Same author

Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration - The OCTOPUS cohort study.

Journal francais d'ophtalmologie·2025
Same author

Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration - The SWIFT study.

Journal francais d'ophtalmologie·2025
Same author

[Recommendations for rational use of new anti-VEGF biologicals].

Journal francais d'ophtalmologie·2025
Same author

[Ophthalmic artery occlusion after facial autologous fat injection].

Journal francais d'ophtalmologie·2025
Same author

[Cataract surgery training in France: Analysis of the results of the European Board of Ophthalmology survey in the French cohort].

Journal francais d'ophtalmologie·2024
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
Same journal

Granulomatous reaction after hybrid hyaluronic acid-calcium hydroxyapatite filler injection in supratarsal hollow correction.

Journal francais d'ophtalmologie·2026
Same journal

Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

Journal francais d'ophtalmologie·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pharmacokinetics

Context:

  • The ocular surface acts as a critical interface between the host and the external environment.
  • It is constantly exposed to physical parameters like air and humidity, and microorganisms.
  • Maintaining the delicate balance on the ocular surface is essential for eye health.

Purpose:

  • To elucidate fundamental pharmacokinetic and microbiology principles relevant to the ocular surface.
  • To provide a foundational understanding for managing ocular surface conditions.
  • To highlight the interaction between host cells and microorganisms at this interface.

Summary:

  • This review outlines key pharmacokinetic and microbiology concepts applicable to the ocular surface.
  • It emphasizes the fragile balance maintained at this biological boundary.

Related Experiment Videos

  • The study details the interplay between host cells and external microbes.
  • Impact:

    • Provides essential knowledge for developing effective ocular therapies.
    • Enhances understanding of ocular surface dynamics and disease mechanisms.
    • Aids in the development of strategies to manage microbial challenges on the eye.